The results showed that DLGAP1-AS2 knockdown drastically inhibited, whereas DLGAP1-AS2 overexpression promoted CRC metastasis (Fig. 3G and Fig.S3A-B). This evidence concerns the gene DLGAP1 and colorectal carcinoma.